chrisvoncsefalvay/vaers-outcomes huggingface dataset:
felt a little warmth in their body that passed quickly; tong begun to burn, like when one eats spicy food and still remains, but it is fading; arm also developed a little black and blue (bruise) on the site of the injection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING HOT (felt a little warmth in their body that passed quickly), TONGUE DISCOMFORT (tong begun to burn, like when one eats spicy food and still remains, but it is fading) and VACCINATION SITE BRUISING (arm also developed a little black and blue (bruise) on the site of the injection) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced FEELING HOT (felt a little warmth in their body that passed quickly), TONGUE DISCOMFORT (tong begun to burn, like when one eats spicy food and still remains, but it is fading) and VACCINATION SITE BRUISING (arm also developed a little black and blue (bruise) on the site of the injection). On 16-Jan-2021, FEELING HOT (felt a little warmth in their body that passed quickly) had resolved. At the time of the report, TONGUE DISCOMFORT (tong begun to burn, like when one eats spicy food and still remains, but it is fading) and VACCINATION SITE BRUISING (arm also developed a little black and blue (bruise) on the site of the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment medications were reported.
Patient with mild erythema and macular rash on the anterior lateral aspect of left arm approxiamately 1.5 cm in width with no swelling or warmth to site.
became shirt of breath about 5minutes after getting the shot; This is spontaneous report from contactable consumer, the patient. A 20-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727), via an unspecified route of administration, in left arm on 17Mar2021 at 11:00, (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient have no allergies to medications, food, or other products. Patient did not receive any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested positive for COVID-19. On 17Mar2021 at 11:15, the patient experienced short of breath about 5 minutes after getting the shot. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of shortness of breath was resolving. No follow-up attempts are possible. No further information is expected.
Patient had a hypoglycemic and Syncopal event resulting in car accident, ~ 6 hours after vaccine administration
Unconsolable screaming for almost an hour, fever of 100.1, redness, swelling, and pain on right leg at injection site.
11pm Migraine lasted 10 days 2am chest pain, palpitations, throbbing lasted 24h 3am pain in wrists and elbows lasted 2 days 7am muscle pain lasted 4 days 7am fatigue lasted 10 days  7am nausea, diarrhea throwing up lasted 2 days 12 pm swollen gland in neck under arms ant groin lasted 24 hours 5pm fever chills lasted 24 hours
Headache,  fever, nausea, body aches; fever; nausea; body aches; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 13:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was taking prescribed medication (unspecified) within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 13:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. On 20Apr2021 at 00:00, the patient experienced headache, fever, nausea and body aches. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache, fever, nausea and body aches was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
very congested due to my seasonal allergies; have an ear infection which is not treated yet; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (very congested due to my seasonal allergies) and EAR INFECTION (have an ear infection which is not treated yet) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Lot# 045A21A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Seasonal allergy.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (very congested due to my seasonal allergies) and EAR INFECTION (have an ear infection which is not treated yet). At the time of the report, NASAL CONGESTION (very congested due to my seasonal allergies) and EAR INFECTION (have an ear infection which is not treated yet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment drugs were reported
Pt called on 5/26/09 c/o feeling nervousness. States that it started ~ 3 days after receiving Adacel inj. which he is still having the SX. as of appt on 5/28/09
About 20 min after injection fingers and face on side of injection became tingling and experienced slight numbness.  This continued for a few hours.  Beyond that have just experienced a continuous headache relieved by Tylenol and Motrin.
Vertigo, nausea/vomiting, diaphoresis a few minutes up to 10 minutes every few days until the symptoms became very severe and would not subside on 5/16/2021 around 5 am. And continued frequently all day on 5/16/2021 and went to the Emergency Room on 5/17/2031 and found to have a right cerebellar stroke.
A report was received from a health professional on 11/21/2002, concerning a 65 year old female vaccinee who experienced upper extremity weakness, pain, swelling and tenderness from the site of administration at the deltoid muscle down to the fingertips, 16 days after receiving Fluvirin on 10/29/2002.  On 11/14/2002, the vaccinee's upper extremity became weak, painful, swollen and tender from the site of injection at the deltoid muscle down to the fingertips.  The vaccinee went to the physician as a result of this event, and was prescribed oral anti-inflammatory medication.  The event had partially resolved at the time of reporting, but was still present.  The vaccinee did not received any other injections in the affected upper extremity either before or after the Fluvirin injection.  The vaccinee has received Fluvirin in previous years without any adverse or untoward event.  The vaccinee has no known medciation or other allergies.  The reporter has assessed the relationship of the vaccine to the vent as probable.  Update 1, 12/10/2002:  An update report received from a healthcare professional indicated that the vaccinee did not experience soreness, swelling, redness or bruising at the injection site.  However, 16 days after receiving Fluvirin, the vaccinee experienced pain in the right arm to touch and was having difficulty lifting her right arm.  The vaccinee was treated with 7.5mg melocain bid.  At the time of reporting the vaccinee had not yet recovered.  The vaccinee's physician suggested that the event was an adverse reaction to the Fluvirin.
Episode of ischemic colitis of proximal sigmoid colon occurring within 6 hours of receive vaccine. This required hospitalization.
Rashes and hives on my hands, then feet then legs  exactly 1 week after my vaccination.  Itching started on the back of my hands and then progressed to the tops of my feet and rose up my legs, I took 2 Benadryl and went to urgent care.  The Benadryl started working within a half hour of taking it.   The itching started as o laid in bed where the only food or liquid I consumed before getting out of bed was a bottled water.  The doctor stated that I may be allergic to the pba?s in the water bottle.   I have never been allergic to this before  I was given this vaccine.  Intense itching and  hives have been occurring  ever since that day and without taking Claritin  or Benadryl daily  the itching and hives takes over my whole body.  I fear I could go into anaphylaxis if I do not take this medication.  I have cut out several different foods and different liquids including bottled water and have fasted yet still am getting a allergic reaction.  I saw my family dr and he said it?s likely due to the Johnson and Johnson covid 19 vaccine and I believe that to be true.  Other symptoms include facial flushing and upset stomach
74hrs post vaccination - nausea and muscle spasms. Couldn?t control the rapid muscle flexing throughout. Especially in lower half. Went to ER and was given Ibuprofen and zofran as subdued.   100hrs plus post vaccination - nausea and fog when moving around on days 4,5,6, and 7 post vaccination. When sitting idle nausea goes away. Mid-day a chest tightness and breathing shortness becomes prevalent and continues through the afternoon and evening
redness and swelling at injection site and beyond, worsening rash.  Patient was given abx in office due to ear infection as well.
The evening after the 2nd vaccine, went to sleep with fever, chills and body aches. Was awakened with vertigo. The room seemed to be spinning out of control every time I turned over ion bed. The vertigo subsided the next day, but returned 2 weeks later for a few nights. It has since passed, but I worry about it returning.
On 12/21/04 had flair up of eczema on upper body. By 12/23/04 eczema it had spread over his entire body. Mom consulted with his dermatologist.
This spontaneous report as received from a pharmacist via company representative refers to a patient of unknown age and gender. The patient's pertinent medical history, current conditions and concomitant medications were not reported. No previous drug reactions or allergies were reported. On an unknown date the patient was vaccinated with ZOSTAVAX vial 19400 PFU (dosing details wer not reported). The reporter stated that during administration of a dose of ZOSTAVAX to an unspecified patient on an unknown date, after withdrawing the needle from the patient's arm, some of the ZOSTAVAX may have leaked back out of the injection site, possibly resulting in administration of a partial dose of ZOSTAVAX (injection site leaking and under dose). No adverse effect reported. The reporter did not provide the causality assessment between the event (injection site leaking) and the suspect therapy. There was no product quality complaint involved. Additional information has been requested.
Patient was given 2 vaccines, one in each arm. After administration, patient asked to lay down, her face went pale, lips pale, she got up & attempted to lay on exam table. She hit her knees on empty garbage can. PH & mother helped her to floor no fall but guide to floor.
Tested NAAT positive for COVID-19 11/8/2021 after being fully vaccinated.
Treatment of COVID-19; Treatment of COVID-19; Pfizer vaccine: 26Oct2021 and Moderna vaccine: 09May2022; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Oct2021 as dose number unknown, single (Lot number: 320308D) at the age of 63 years for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 09May2022 as dose number unknown, single (Lot number: 057M21A) for covid-19 immunisation. The patient's relevant medical history included: "IBS" (unspecified if ongoing). The patient's concomitant medications were not reported.  The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 09May2022, outcome "unknown", described as "Pfizer vaccine: 26Oct2021 and Moderna vaccine: 09May2022"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Feb2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.
can't speak because his throat is so bad; fever 100.8 last night of 16Mar2021; throat was swollen; throat was painful/throat is still sore; tonsillitis; tickle in the throat; This is a spontaneous report from a contactable healthcare professional (patient's friend). A 30-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration on 11Mar2021 16:00 as single dose for COVID-19 immunisation. Medical history included patient was a kidney donor and has only one kidney. There were no concomitant medications. Podiatrist calling for a friend who can't speak because his throat was so bad on an unspecified date. Adds the patient got the first dose of the Pfizer COVID 19 vaccine Thursday 11Mar2021 at 1600 in an unknown site. Friday (12Mar2021) and Saturday (13Mar2021), he had a tickle in his throat. His throat was swollen and painful on 14Mar2021 and he couldn't stand it and went to the ER. On 14Mar2021, at the ER he had a negative Strep test and was told he had tonsillitis and was given antibiotics. Clarifies patient was treated with Zithromax for 5 days. Adds yesterday he said he had three more days of antibiotics. Reports today the patient was only able to eat ice pops and his throat was still swollen although he was getting better. He said his throat was still sore and he has been too afraid to eat anything except popsicles but was planning to try soup. Mentions patient said he had a fever last night 16Mar2021 of 100.8. They were trying to figure out if this was related to the vaccine or did he get sick with something else and should he get the next dose. States the second dose was scheduled for 01Apr2021. The events tickle in the throat, throat was swollen, and throat was painful/throat is still sore resulted in emergency room visit and was considered as medically significant. Therapeutic measures were taken as a result of tickle in the throat, throat was swollen, throat was painful/throat is still sore, can't speak because his throat is so bad, and tonsillitis. The outcome of the events tonsillitis and can't speak because his throat is so bad was unknown and recovering for the rest of the events.  Information about lot/batch has been requested.; Sender's Comments: Based on the information currently available, a possible contributory role of the suspect drug to the reported events "tickle in the throat, throat was swollen and throat was painful/throat is still sore" cannot be completely excluded based on temporal association.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identifies as part of this review, as well as any appropriate action in response, will be promptly notifies to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
rcvd shingles vaccine 2nd dose. a few days later I started having swelling and a red blotch on my red. A few days later I noticed red like sunburn on the inside of my sides. It lasted for about a week.
Information regarding PREVNAR was received from a healthcare professional regarding a 15 month old male patient who experienced hives and generalized rash. The patient received a dose on 27 Jun 2008. No known food or drug allergies. Indication for PREVNAR. Product was administered on 27 Jun 2008. Dose regimen was 1 dose 1 time per day. Additional suspect medication included INFANRIX IPV and HIB. Concomitant medications were not reported. The patient experienced hives and generalized rash on 03 Jul 2008. The patient recovered. No additional information was available at the time of this report.
Atrial Fibrillation; allergic reaction to the vaccine; This case was reported by a consumer via call center representative and described the occurrence of atrial fibrillation in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date). Concurrent medical conditions included multiple allergies (to OTC products, pharma products and huge allergies).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced atrial fibrillation (serious criteria GSK medically significant) and allergic reaction. On an unknown date, the outcome of the atrial fibrillation was recovered/resolved and the outcome of the allergic reaction was unknown.   It was unknown if the reporter considered the atrial fibrillation and allergic reaction to be related to Shingrix.  Additional details were provided as follows: This case was reported by patient herself. The age at vaccination was not reported but could be 76 or 77 years. In late 2019 or the beginning of 2020, the patient received 2nd dose of Shingrix and the next day, she had atrial fibrillation, which resolved within 24 to 48 hours, however, she did go to the emergency room but was not admitted. The patient claimed that she experienced an allergic reaction to the vaccine and also mentioned that up until that point she did not had any reaction to any vaccines and now with vaccines as she was getting older. Emergency room visit required. The reporter consented to follow-up.
Initial report received from a health care professional on 28 October 2013. A 61 year old female patient, whose medical history and concomitant medications were not reported, had received a dose of FLUZONE vaccine (Lot number UH904AA, route and site of vaccination were not reported), on unknown date. On 28-Oct-2013, when she tried to flip the cap off the MDV the vial broke off at the neck and a piece of glass went into her right thumb. There was no bleeding and the shred of glass was easily removed. At the time of reporting, outcome of the event was unknown. No further relevant information was reported. Documents held by sender: none.
Pain at injection site. Progress to under the arm. Also lymph nodes under arm are noticeable to the touch and water build up on the right under arm chest wall. Some coldness in hand and occasional tingling. Shoulder area feels heavy.
Despite vaccination, pt developed severe case of zoster in perineal and rectal region (L) side
on 10/25/2023 around 8 AM pt.'s mother called to report when pt. woke up, he let her know he had "lost feeling" in his right arm. He said he was unable to move his fingers and torso when this happened. He could move his head and neck, but it hurt when he did. He said his left arm was burning, like it was on fire. He was unsure how long the event lasted. By 1 PM on 10/25/2023 all symptoms had stopped, he was able to move both arms with no issue. Mom reported he was back to normal, just "lethargic" which she felt was due to him not sleeping well. On 10/26/2023 around 9 AM, pt. reported no more previous symptoms. Only c/o a headache when he woke up which was causing pain behind his eye, this was all on the right side. Mom gave Advil which made the headache and eye pain stop. By 10/27/2023 around 4:45 PM pt. was completely back to normal, no prior symptoms were present. Mom suspected all of this was due to the Trumemba because he had not received it before, even though all events occurred on the right side.
Mother reports pt had redness, itching at vaccine site on left arm on the afternoon after vaccine given. Redness has increased over the last 2 days.
Worsening migraines and daily headaches with electrical impulses... Treated with Botox, Depakote, Sumatriptan injection, Ubrelvy,  Nurtec, Excedrin Migraine...went in hospital three times to emergency room,  stayed in hospital 5 days...still currently have all the symptoms as noted above
Excessive nose bleed, platelet count dropped to 7K, low hemoglobin, severe anemia; diagnosed with Thrombotic Thrombocytopenia purpura. Urgent Care visit 6/20/21 - sent to ER. ER ran tests and admitted her. She was hospitalized for 12 days.  Discharged. Fainted and fell; returned to ER. Platelets fell to 30K after five plasmapherisis.  See below for all tests.  Still hospitalized now.
Site: Pain at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Severe, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Severe, Systemic: Autoimmune Disease (diagnosed by MD)-Medium, Systemic: Bell's Palsy-Medium, Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Additional Details: swelling of the eyes and itchiness.
Information has been received from a nurse referring to an unspecified number of unspecified patients of unknown age and gender. Information about concurrent condition, drug reactions/allergies and medical history was unknown. Concomitant therapies included sterile diluent. From 07-JUL-2017 to 09-AUG-2017, the patients each was vaccinated with improperly stored doses of PROQUAD (dose and route unknown, lot # N010865 with expiry date 01-OCT-2018, N004631 with expiry date 07-AUG-2018 and M019232 with expiry date 17-OCT-2017) for prophylaxis. No adverse effect was reported. The vaccines were under the temperature ranged of -14 degree Celsius to -10 degree Celsius for 24 hours, -9 degree Celsius to 8 degree Celsius for 24 hours and 9 degree Celsius to 25 degree Celsius for 24 hours. There was no previous temperature excursion. A data digital logger was used. Sender's Comments: US-009507513-1709USA004452: US-009507513-1708USA006160.
Injection site was red with swelling, big blisters started growing (3/4" in size), red area expanded to 5"+, and later to 8"+.  We have photos if you would like to see the reaction.  Patient has not experienced a fever.
First day: Arm pain, followed by a severe headache lasting approximately 24 hours, with pain in extremities, joints, ankles, wrists, knees, neck pain, high fevers and intermittent sweating. Something that triggered me and that I had never suffered before was ALLERGIES TO POLLEN. Today a week later I still feel sick from it. A lot of headache, runny nose, and sneezing. I assume they are allergies to pollen because I took some pills for that {CLARITIN} and I calm down and we feel them a bit, however I do not take it off.
pt recv flu vax instead of TB skin test,pt devel a reddened area @ inj site;no other details were known as of the reporting date;
Tdap was given 5/19/08 at 1520. She complained of headache next day. On the 2nd after vaccine she complained of headache, dizziness, nausea, GI cramping, gas and pain and small amount of rectal bleeding.